Drug Type CAR-NK |
Synonyms AB 205, AB205 |
Target |
Mechanism T-cell surface glycoprotein CD5 inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
T-Cell Lymphoma | Preclinical | US | Artiva Biotherapeutics, Inc.Startup | 24 Aug 2023 |
T-Cell Lymphoma | Preclinical | KR | 24 Aug 2023 |